Norry Elliot (CIK 1798117) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-01-17). Recent activity: Sell ADAP (5,584 shares), Sell ADAP (4,268 shares), Sell ADAP (8,124 shares), Sell ADAP (9,803 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-17 | Adaptimmune Therapeutics PLC (ADAP) | Chief Medical Officer | Sell | 5,584 | $3,239 |
| 2025-01-15 | Adaptimmune Therapeutics PLC (ADAP) | Chief Medical Officer | Sell | 4,268 | $2,518 |
| 2025-01-15 | Adaptimmune Therapeutics PLC (ADAP) | Chief Medical Officer | Sell | 8,124 | $4,793 |
| 2025-01-15 | Adaptimmune Therapeutics PLC (ADAP) | Chief Medical Officer | Sell | 9,803 | $5,588 |
Source: SEC Form 4 filings · as of 2025-01-17